SS Innovations International (NASDAQ: SSII) is strengthening its position in the emerging telerobotic surgery market as advances in surgical robotics and communications technology create new opportunities for remote medical procedures. The company's SSi Mantra surgical robotic system has supported 195 robotic telesurgeries as of September 28, 2026, including cardiac procedures and operations performed across significant geographic distances.
The milestone matters because telesurgery could extend specialized surgical expertise to regions where such care is scarce. Remote procedures allow surgeons to operate on patients hundreds or thousands of miles away, potentially widening access to complex operations such as cardiac surgery. SS Innovations is pursuing that opportunity with a platform designed to make robotic surgery more affordable and accessible to a larger segment of the global population.
Alongside its telesurgery developments, SS Innovations reported a 45% increase in its installed base to 244 systems across 12 countries, with cumulative surgical procedures reaching 14,503 and approximately 1,500 physicians trained on the platform. Recent international expansion includes new robotic cardiac surgery programs in Colombia, Sri Lanka, and India. The company is also pursuing U.S. FDA clearance and European Union CE marking to support entry into additional markets.
Those regulatory efforts are significant for investors and the medical technology industry. FDA clearance and CE marking would open two of the world's largest and most regulated healthcare markets, where demand for surgical robotics continues to grow. The installed base growth and physician training figures also suggest that adoption is moving beyond early pilots into broader clinical use.
SS Innovations, headquartered in India and structured as a U.S. company, develops the SSi Mantra system and its SSi Mudra surgical instruments, which support a variety of robotic procedures including cardiac surgery. The company frames its mission around cost-effective, user-friendly robotic solutions, a positioning that could matter in price-sensitive health systems across emerging markets.
For readers and industry observers, the announcement highlights how communications infrastructure and robotics are converging to make remote surgery more feasible. The 195 telesurgeries represent real-world evidence, not just laboratory demonstrations, and the cardiac cases in particular point to the complexity of procedures being attempted remotely.
TechMediaWire, which published the update, is a specialized communications platform focused on technology companies and is one of more than 75 brands within the Dynamic Brand Portfolio at IBN. The platform distributes content through wire services including InvestorWire, editorial syndication to 5,000+ outlets, corporate communications solutions, and social media distribution. Full terms and disclaimers are available on the TechMediaWire disclaimer page. The company's newsroom can be found at https://ibn.fm/SSII, and its website at SSInnovations.com.
